Call for Abstract
Scientific Program
9th International conference on Clinical Research and Diagnosis, will be organized around the theme “An established clinical research attributes rigorous clinical trials and good clinical practice ”
Clinical Research and Diagnosis 2018 is comprised of 17 tracks and 80 sessions designed to offer comprehensive sessions that address current issues in Clinical Research and Diagnosis 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Eligibility criteria
- Track 1-2Patient selection process
- Track 1-3Ethical considerations
- Track 1-4Selection of controls
- Track 3-1Database Development
- Track 3-2Development of Case Report Forms
- Track 3-3Clinical Research Data Standards
- Track 3-4Analysis of Study Data
- Track 3-5Important Considerations
- Track 3-6Analysis Methods
- Track 3-7Clinical Study in Project Management
- Track 4-1Sponsorship in non-commercial clinical trials
- Track 4-2Regulatory challenges associated with conducting multi-country clinical trials in resource-limited settings
- Track 4-3Site-Sponsor Relationship in Clinical Studies: Problems and Solutions
- Track 4-4Site Sustainability Factors
- Track 4-5How Partnerships Evolve
- Track 4-6How do Sponsors and CROs Feel About Sites
- Track 4-7How to make Site-Sponsor Relationship Work Better for Both Sides
- Track 5-1clinical outcomes
- Track 5-2Surrogate outcomes
- Track 5-3Multiple outcomes
- Track 6-1Clinical trials for Alzheimer’s
- Track 6-2Trials on pulmonary/respiratory diseases
- Track 6-3Clinical trials for rare diseases: Challenges and opportunities
- Track 6-4Clinical trials for diabetes and cardiovascular diseases
- Track 6-5Clinical trials on Oncology and AIDS
- Track 7-1epidemiologic studies of risk factors for the disease
- Track 7-2in vitro characterization of the chemical and biochemical interactions of new drugs
- Track 7-3pharmacokinetics, pharmacodynamics and Toxicology
- Track 7-4reproductive and embryologic effects as a function of dose
- Track 7-5in vivo drug-drug interactions
- Track 8-1Criteria for application
- Track 8-2Application contents
- Track 8-3IND types
- Track 8-4Additional regulations
- Track 10-1Patient-oriented research
- Track 10-2Epidemiologic and behavioral studies
- Track 10-3Outcomes research and health services research
- Track 10-4Ethical Principles of Clinical Research
- Track 10-5Clinical Trial Process
- Track 11-1TRANSMISSION TO CPMP (COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE)
- Track 11-2TRANSMISSION TO INTERESTED PARTIES
- Track 11-3DEADLINE FOR COMMENTS
- Track 11-4FINAL APPROVAL BY CPMP (COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE)
- Track 11-5DATE FOR COMING INTO OPERATION
- Track 12-1Prevention trials
- Track 12-2Screening trials
- Track 12-3Diagnostic trials
- Track 12-4Treatment trials
- Track 12-5Behavioral trials
- Track 12-6Quality of life trials
- Track 13-1Active comparator studies
- Track 13-2Master protocol
- Track 13-3Clinical trial protocol
- Track 13-4Design features
- Track 13-5Placebo groups
- Track 13-6Treatment studies (Randomized controlled trial, Adaptive clinical trial, Non-randomized trial)
- Track 13-7Observational studies (Descriptive, Analytical)
- Track 14-1Clinical trial results in clinical practice
- Track 14-2Diabetes Research and Clinical Practice, prevention, technologies and therapy, complications, new treatments
- Track 14-3Researches and innovations in cardiology, epidemiology, pathology, parasitology, microbiology, radiotherapy, neurology, pediatrics, nutrition and child care
- Track 14-4Practical approaches to disease management, pain management and rehabilitation
- Track 14-5Epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy
- Track 14-6Studies and case reports on oncology, radiology, immunology, neurophysiology, clinical biochemistry, bioengineering, ageing, allergy, cancer- diagnosis, treatments and therapy
- Track 14-7Anatomy and physiological studies
- Track 14-8Personal perspectives in treating a disease
- Track 14-9Multidisciplinary team approaches to care
- Track 14-10Translational science, genetics, immunology, nutrition, psychosocial research
- Track 15-1Human Clinical Trial Phases
- Track 15-2Participating in a Clinical Trial
- Track 15-3Funding Clinical Trials
- Track 15-4Patient Education Resources
- Track 16-1New chemical entity development
- Track 16-2Valuation
- Track 16-3Success rate
- Track 16-4Novel initiatives to boost development
- Track 17-1Drug targets
- Track 17-2Rational drug discovery
- Track 17-3Computer-aided drug design
- Track 17-4ligand based and Structure based drug designs